{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:12:09Z","timestamp":1790327529552,"version":"4.1.0"},"reference-count":51,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec id=\"S0317167126106696_as1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Tenecteplase is a genetically modified variant of alteplase that is administered as an intravenous bolus and has greater fibrin-specificity and a longer half-life. Data from the Alteplase compared to Tenecteplase (AcT) trial showed non-inferiority of tenecteplase compared to alteplase in patients with acute ischemic stroke (AIS) treated within 4.5 hours of symptom onset, with the direction of effect favoring tenecteplase. Based on this evidence, the Canadian Stroke Best Practice Recommendations added tenecteplase as an alternative to alteplase. Its cost-effectiveness in the Canadian setting, however, remains to be determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0317167126106696_as2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cost-effectiveness analysis of tenecteplase versus alteplase for AIS in the Canadian setting was performed. The model combined a decision tree for the 90 days post-index stroke, where patient distributions across seven modified Rankin Scale states were informed by the AcT trial, and a Markov model for the remainder of the lifetime horizon. Cost-effectiveness was assessed as the incremental cost per quality-adjusted life-year (QALY) gained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0317167126106696_as3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The analysis demonstrated tenecteplase to dominate alteplase (i.e., produced 0.138 more QALYs and \uff04877 savings per AIS patient). Tenecteplase dominance was achieved as early as 90 days post-AIS and confirmed by numerous sensitivity\/scenario analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0317167126106696_as4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This analysis represents the first to assess the cost-effectiveness of tenecteplase as an alternative to alteplase in the treatment of AIS in the Canadian setting. Though all benefits related to its simplified bolus administration were not considered, results robustly demonstrate tenecteplase represents a high-value strategy. Together with the accumulating clinical evidence, this study may help support decisions to adopt tenecteplase on hospital formularies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/cjn.2026.10669","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:52:04Z","timestamp":1790326324000},"page":"1-11","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of Tenecteplase Versus Alteplase for Acute Ischemic Stroke in Canada Based on the AcT Trial"],"prefix":"10.1017","author":[{"given":"Marie-Claude","family":"Aubin","sequence":"first","affiliation":[{"name":"Hoffman-La Roche Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2423-3779","authenticated-orcid":false,"given":"Debbie L.","family":"Becker","sequence":"additional","affiliation":[{"name":"Quadrant Health Economics Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Cartier","sequence":"additional","affiliation":[{"name":"Quadrant Health Economics Inc"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce J.","family":"Zheng","sequence":"additional","affiliation":[{"name":"Hoffman-La Roche Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Notte","sequence":"additional","affiliation":[{"name":"Hoffman-La Roche Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Blacquiere","sequence":"additional","affiliation":[{"name":"University of Ottawa Faculty of Medicine"},{"name":"The Ottawa Hospital Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijoy K.","family":"Menon","sequence":"additional","affiliation":[{"name":"University of Calgary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"S0317167126106696_ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163677"},{"key":"S0317167126106696_ref3","unstructured":"3. World Health Organization. Stroke, cerebrovascular accident. Accessed March 27, 2025. https:\/\/www.emro.who.int\/health-topics\/stroke-cerebrovascular-accident\/index.html."},{"key":"S0317167126106696_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102758"},{"key":"S0317167126106696_ref30","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.602615"},{"key":"S0317167126106696_ref31","doi-asserted-by":"publisher","DOI":"10.25318\/1310011401-eng"},{"key":"S0317167126106696_ref11","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.125.052121"},{"key":"S0317167126106696_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.015"},{"key":"S0317167126106696_ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1747493018786616"},{"key":"S0317167126106696_ref35","unstructured":"35. Hoffmann-La Roche Limited. PrTNKase\u00ae (tenecteplase for injection). Product Monograph.2025."},{"key":"S0317167126106696_ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06669-w"},{"key":"S0317167126106696_ref12","unstructured":"12. Hoffmann-La Roche Limited. PrACTIVASE\u00ae rt-PA (alteplase for injection). Product Monograph. 2024."},{"key":"S0317167126106696_ref25","doi-asserted-by":"publisher","DOI":"10.1177\/23969873231174943"},{"key":"S0317167126106696_ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332401"},{"key":"S0317167126106696_ref27","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-018420"},{"key":"S0317167126106696_ref38","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006200"},{"key":"S0317167126106696_ref46","first-page":"6","article-title":"The opportunity for Canada and Australia to learn from one anothers health systems","volume":"20","author":"Pervan","year":"2025","journal-title":"Healthc Policy"},{"key":"S0317167126106696_ref47","unstructured":"47. Canada\u2019s Drug Agency (CDA). Procedures reimbursement reviews. 2024. Accessed January 31, 2025. https:\/\/www.cadth.ca\/sites\/default\/files\/Drug_Review_Process\/CADTH_Drug_Reimbursement_Review_Procedures.pdf."},{"key":"S0317167126106696_ref48","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198526629.001.0001"},{"key":"S0317167126106696_ref51","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.122.038950"},{"key":"S0317167126106696_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00151-6"},{"key":"S0317167126106696_ref45","doi-asserted-by":"publisher","DOI":"10.1177\/0840470418788378"},{"key":"S0317167126106696_ref32","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.028992"},{"key":"S0317167126106696_ref19","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1041561"},{"key":"S0317167126106696_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00163-X"},{"key":"S0317167126106696_ref14","unstructured":"14. Statistics Canada. Table 18-10-0006-01 consumer price index, monthly, seasonally adjusted. Accessed November 26, 2024. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1810000601."},{"key":"S0317167126106696_ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1747493017744464"},{"key":"S0317167126106696_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60584-5"},{"key":"S0317167126106696_ref17","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013644"},{"key":"S0317167126106696_ref23","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20220096"},{"key":"S0317167126106696_ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110525"},{"key":"S0317167126106696_ref40","unstructured":"40. Centre hospitalier de lUniversit\u00e9 de Montr\u00e9al (CHUM). Interdisciplinary protocol for the administration of thrombolysis in a patient with an acute ischemic stroke. Protocol-0026. May 31 2023."},{"key":"S0317167126106696_ref42","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100015638"},{"key":"S0317167126106696_ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649503"},{"key":"S0317167126106696_ref6","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2022.344"},{"key":"S0317167126106696_ref4","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2022.338"},{"key":"S0317167126106696_ref34","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.008547"},{"key":"S0317167126106696_ref39","unstructured":"39. Rogoza, R , Motsepe-Ditshego, P. Description of, and healthcare resource utilization of atherosclerotic cardiovascular disease (ASCVD) in Ontario, Canada (Institute for Clinical Evaluative Sciences; DAS Project No. 2018 0970 092 000). 2020. Accessed August 11, 2024. https:\/\/www.ices.on.ca\/services-for-researchers\/all-projects\/private-sector-projects\/description-and-healthcare-resource-utilization-of-atherosclerotic-cardiovascular-disease-in-ontario-canada\/."},{"key":"S0317167126106696_ref43","doi-asserted-by":"publisher","DOI":"10.3111\/200508147167"},{"key":"S0317167126106696_ref44","doi-asserted-by":"publisher","DOI":"10.1017\/S1744133117000421"},{"key":"S0317167126106696_ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.03.043"},{"key":"S0317167126106696_ref22","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1474746"},{"key":"S0317167126106696_ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065133"},{"key":"S0317167126106696_ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00530-4"},{"key":"S0317167126106696_ref21","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.615682"},{"key":"S0317167126106696_ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3767"},{"key":"S0317167126106696_ref49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209903"},{"key":"S0317167126106696_ref20","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.029666"},{"key":"S0317167126106696_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01054-6"},{"key":"S0317167126106696_ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.043369"},{"key":"S0317167126106696_ref41","doi-asserted-by":"publisher","DOI":"10.1159\/000536011"},{"key":"S0317167126106696_ref36","unstructured":"36. MED NEEDLES. Med needles. Accessed February 28, 2025. https:\/\/medneedles.ca\/collections\/."}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167126106696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:52:09Z","timestamp":1790326329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167126106696\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":51,"alternative-id":["S0317167126106696"],"URL":"https:\/\/doi.org\/10.1017\/cjn.2026.10669","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}